2 Ultra Safe Dividend Stocks to Buy Now
Historically, blue-chip dividend stocks have been good choices for periods…
Sell
39
DXC Quote, Financials, Valuation and Earnings
Last price:
$15.20
Seasonality move
:
-5.58%
Day range:
$14.99 - $15.42
52-week range:
$13.44 - $24.83
Dividend yield:
0%
P/E ratio:
7.20x
P/S ratio:
0.22x
P/B ratio:
0.85x
Volume:
2.2M
Avg. volume:
1.7M
1-year change:
0.4%
Market cap:
$2.8B
Revenue:
$12.9B
EPS (TTM):
$2.11
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $17.7B | $16.3B | $14.4B | $13.7B | $12.9B | |
| Revenue Growth (YoY) | -9.44% | -8.26% | -11.28% | -5.29% | -5.82% | |
| Cost of Revenues | $14.1B | $12.7B | $11.2B | $10.6B | $9.8B | |
| Gross Profit | $3.6B | $3.6B | $3.2B | $3.1B | $3.1B | |
| Gross Profit Margin | 20.55% | 22.02% | 22.07% | 22.62% | 24.09% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.1B | $724M | $2.8B | $1.7B | $1.1B | |
| Other Inc / (Exp) | $1.3B | $139M | $321M | $195M | -$2M | |
| Operating Expenses | $4B | $2.4B | $4.3B | $3.1B | $2.4B | |
| Operating Income | -$393M | $1.1B | -$1.1B | -$2M | $698M | |
| Net Interest Expenses | $263M | $139M | $65M | $84M | $66M | |
| EBT. Incl. Unusual Items | $654M | $1.1B | -$885M | $109M | $630M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $800M | $405M | -$319M | $23M | $234M | |
| Net Income to Company | -$146M | $736M | -$566M | $86M | $396M | |
| Minority Interest in Earnings | -$3M | -$18M | -$2M | $5M | -$7M | |
| Net Income to Common Excl Extra Items | -$149M | $718M | -$568M | $91M | $389M | |
| Basic EPS (Cont. Ops) | -$0.59 | $2.87 | -$2.48 | $0.46 | $2.15 | |
| Diluted EPS (Cont. Ops) | -$0.59 | $2.81 | -$2.48 | $0.46 | $2.10 | |
| Weighted Average Basic Share | $254.1M | $250M | $229M | $195.8M | $180.7M | |
| Weighted Average Diluted Share | $254.1M | $255.2M | $229M | $198.8M | $184.9M | |
| EBITDA | $3B | $3.1B | $866M | $1.8B | $2.2B | |
| EBIT | $1B | $1.3B | -$685M | $407M | $895M | |
| Revenue (Reported) | $17.7B | $16.3B | $14.4B | $13.7B | $12.9B | |
| Operating Income (Reported) | -$393M | $1.1B | -$1.1B | -$2M | $698M | |
| Operating Income (Adjusted) | $1B | $1.3B | -$685M | $407M | $895M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.4B | $4B | $3.6B | $3.4B | $3.2B | |
| Revenue Growth (YoY) | -8.93% | -8.6% | -10.4% | -5.71% | -6.41% | |
| Cost of Revenues | $3.6B | $3.2B | $2.7B | $2.6B | $2.4B | |
| Gross Profit | $824M | $847M | $849M | $798M | $768M | |
| Gross Profit Margin | 18.79% | 21.13% | 23.64% | 23.57% | 24.24% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $471M | -$369M | $1.8B | $740M | $127M | |
| Other Inc / (Exp) | -$613M | $35M | $198M | $2M | $21M | |
| Operating Expenses | $949M | $54M | $2.2B | $1.1B | $439M | |
| Operating Income | -$125M | $793M | -$1.3B | -$291M | $329M | |
| Net Interest Expenses | $55M | $29M | $17M | $20M | $12M | |
| EBT. Incl. Unusual Items | -$793M | $799M | -$1.2B | -$309M | $338M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $11M | $260M | -$405M | -$114M | $75M | |
| Net Income to Company | -$804M | $539M | -$758M | -$195M | $263M | |
| Minority Interest in Earnings | $6M | -$9M | $2M | -$5M | $1M | |
| Net Income to Common Excl Extra Items | -$798M | $530M | -$756M | -$200M | $264M | |
| Basic EPS (Cont. Ops) | -$3.14 | $2.18 | -$3.38 | -$1.10 | $1.46 | |
| Diluted EPS (Cont. Ops) | -$3.14 | $2.14 | -$3.38 | -$1.10 | $1.43 | |
| Weighted Average Basic Share | $254.5M | $242.8M | $224M | $181.2M | $181.1M | |
| Weighted Average Diluted Share | $254.5M | $248.1M | $224M | $184.5M | $185.7M | |
| EBITDA | -$234M | $1.3B | -$718M | $124M | $714M | |
| EBIT | -$716M | $842M | -$1.1B | -$233M | $396M | |
| Revenue (Reported) | $4.4B | $4B | $3.6B | $3.4B | $3.2B | |
| Operating Income (Reported) | -$125M | $793M | -$1.3B | -$291M | $329M | |
| Operating Income (Adjusted) | -$716M | $842M | -$1.1B | -$233M | $396M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $17.7B | $16.3B | $14.4B | $13.7B | $12.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $14.1B | $12.7B | $11.2B | $10.6B | $9.8B | |
| Gross Profit | $3.6B | $3.6B | $3.2B | $3.1B | $3.1B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2.1B | $724M | $2.8B | $1.7B | $1.1B | |
| Other Inc / (Exp) | $1.3B | $139M | $321M | $195M | -$2M | |
| Operating Expenses | $4B | $2.4B | $4.3B | $3.1B | $2.4B | |
| Operating Income | -$393M | $1.1B | -$1.1B | -$2M | $698M | |
| Net Interest Expenses | $263M | $139M | $65M | $84M | $66M | |
| EBT. Incl. Unusual Items | $654M | $1.1B | -$885M | $109M | $630M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $800M | $405M | -$319M | $23M | $234M | |
| Net Income to Company | -$146M | $736M | -$566M | $86M | $396M | |
| Minority Interest in Earnings | -$3M | -$18M | -$2M | $5M | -$7M | |
| Net Income to Common Excl Extra Items | -$149M | $718M | -$568M | $91M | $389M | |
| Basic EPS (Cont. Ops) | -$0.59 | $2.92 | -$2.56 | $0.38 | $2.14 | |
| Diluted EPS (Cont. Ops) | -$0.62 | $2.85 | -$2.58 | $0.37 | $2.11 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $3B | $3.1B | $866M | $1.8B | $2.2B | |
| EBIT | $1B | $1.3B | -$685M | $407M | $895M | |
| Revenue (Reported) | $17.7B | $16.3B | $14.4B | $13.7B | $12.9B | |
| Operating Income (Reported) | -$393M | $1.1B | -$1.1B | -$2M | $698M | |
| Operating Income (Adjusted) | $1B | $1.3B | -$685M | $407M | $895M | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $16.3B | $14.4B | $13.7B | $12.9B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $12.7B | $11.2B | $10.6B | $9.8B | -- | |
| Gross Profit | $3.6B | $3.2B | $3.1B | $3.1B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $724M | $2.8B | $1.7B | $1.1B | -- | |
| Other Inc / (Exp) | $139M | $321M | $195M | -$2M | -- | |
| Operating Expenses | $2.4B | $4.3B | $3.1B | $2.4B | -- | |
| Operating Income | $1.1B | -$1.1B | -$2M | $698M | -- | |
| Net Interest Expenses | $139M | $65M | $84M | $66M | -- | |
| EBT. Incl. Unusual Items | $1.1B | -$885M | $109M | $630M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $405M | -$319M | $23M | $234M | -- | |
| Net Income to Company | $736M | -$566M | $86M | $396M | -- | |
| Minority Interest in Earnings | -$18M | -$2M | $5M | -$7M | -- | |
| Net Income to Common Excl Extra Items | $718M | -$568M | $91M | $389M | -- | |
| Basic EPS (Cont. Ops) | $2.92 | -$2.56 | $0.38 | $2.14 | -- | |
| Diluted EPS (Cont. Ops) | $2.85 | -$2.58 | $0.37 | $2.11 | -- | |
| Weighted Average Basic Share | $1B | $916M | $783.3M | $722.7M | -- | |
| Weighted Average Diluted Share | $1B | $927.6M | $793.2M | $737.3M | -- | |
| EBITDA | $3.1B | $866M | $1.8B | $2.2B | -- | |
| EBIT | $1.3B | -$685M | $407M | $895M | -- | |
| Revenue (Reported) | $16.3B | $14.4B | $13.7B | $12.9B | -- | |
| Operating Income (Reported) | $1.1B | -$1.1B | -$2M | $698M | -- | |
| Operating Income (Adjusted) | $1.3B | -$685M | $407M | $895M | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3B | $2.7B | $1.9B | $1.2B | $1.8B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2B | $1.8B | $1.5B | $1.4B | $1.3B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $567M | $617M | $565M | $512M | $477M | |
| Other Current Assets | $357M | $268M | $255M | $146M | $118M | |
| Total Current Assets | $8.2B | $7.4B | $6.1B | $5.1B | $5.4B | |
| Property Plant And Equipment | $4.3B | $3.5B | $2.9B | $2.4B | $1.9B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $641M | $617M | $539M | $532M | $526M | |
| Other Intangibles | $4B | $3.4B | $2.6B | $2.1B | $1.6B | |
| Other Long-Term Assets | $4.5B | $4.9B | $3.3B | $2.9B | $3B | |
| Total Assets | $22B | $20.1B | $15.8B | $13.9B | $13.2B | |
| Accounts Payable | $914M | $840M | $782M | $846M | $549M | |
| Accrued Expenses | $4.1B | $3.5B | $2.4B | $2B | $1.9B | |
| Current Portion Of Long-Term Debt | $556M | $249M | $176M | $93M | $757M | |
| Current Portion Of Capital Lease Obligations | $816M | $677M | $532M | $460M | $350M | |
| Other Current Liabilities | $118M | $23M | $9M | -- | -- | |
| Total Current Liabilities | $8.2B | $6.9B | $5.2B | $4.4B | $4.4B | |
| Long-Term Debt | $3.8B | $4.6B | $3.6B | $3.6B | $2.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $16.7B | $14.8B | $12B | $10.8B | $9.7B | |
| Common Stock | $3M | $3M | $2M | $2M | $2M | |
| Other Common Equity Adj | -$302M | -$385M | -$774M | -$732M | -$762M | |
| Common Equity | $5B | $5.1B | $3.5B | $2.8B | $3.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $335M | $323M | $323M | $255M | $261M | |
| Total Equity | $5.3B | $5.4B | $3.8B | $3.1B | $3.5B | |
| Total Liabilities and Equity | $22B | $20.1B | $15.8B | $13.9B | $13.2B | |
| Cash and Short Terms | $3B | $2.7B | $1.9B | $1.2B | $1.8B | |
| Total Debt | $4.6B | $5.2B | $3.9B | $3.7B | $3.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3B | $2.7B | $1.9B | $1.2B | $1.8B | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $2B | $1.8B | $1.5B | $1.4B | $1.3B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | $567M | $617M | $565M | $512M | $477M | |
| Other Current Assets | $357M | $268M | $255M | $146M | $118M | |
| Total Current Assets | $8.2B | $7.4B | $6.1B | $5.1B | $5.4B | |
| Property Plant And Equipment | $4.3B | $3.5B | $2.9B | $2.4B | $1.9B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $641M | $617M | $539M | $532M | $526M | |
| Other Intangibles | $4B | $3.4B | $2.6B | $2.1B | $1.6B | |
| Other Long-Term Assets | $4.5B | $4.9B | $3.3B | $2.9B | $3B | |
| Total Assets | $22B | $20.1B | $15.8B | $13.9B | $13.2B | |
| Accounts Payable | $914M | $840M | $782M | $846M | $549M | |
| Accrued Expenses | $4.1B | $3.5B | $2.4B | $2B | $1.9B | |
| Current Portion Of Long-Term Debt | $556M | $249M | $176M | $93M | $757M | |
| Current Portion Of Capital Lease Obligations | $816M | $677M | $532M | $460M | $350M | |
| Other Current Liabilities | $118M | $23M | $9M | -- | -- | |
| Total Current Liabilities | $8.2B | $6.9B | $5.2B | $4.4B | $4.4B | |
| Long-Term Debt | $3.8B | $4.6B | $3.6B | $3.6B | $2.8B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $16.7B | $14.8B | $12B | $10.8B | $9.7B | |
| Common Stock | $3M | $3M | $2M | $2M | $2M | |
| Other Common Equity Adj | -$302M | -$385M | -$774M | -$732M | -$762M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $335M | $323M | $323M | $255M | $261M | |
| Total Equity | $5.3B | $5.4B | $3.8B | $3.1B | $3.5B | |
| Total Liabilities and Equity | $22B | $20.1B | $15.8B | $13.9B | $13.2B | |
| Cash and Short Terms | $3B | $2.7B | $1.9B | $1.2B | $1.8B | |
| Total Debt | $4.6B | $5.2B | $3.9B | $3.7B | $3.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$146M | $736M | -$566M | $86M | $396M | |
| Depreciation & Amoritzation | $2B | $1.7B | $1.6B | $1.4B | $1.3B | |
| Stock-Based Compensation | $56M | $101M | $108M | $109M | $79M | |
| Change in Accounts Receivable | $257M | $228M | $412M | $176M | $320M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $124M | $1.5B | $1.4B | $1.4B | $1.4B | |
| Capital Expenditures | $515M | $549M | $455M | $407M | $576M | |
| Cash Acquisitions | $5.1B | $533M | -$147M | $26M | $26M | |
| Cash From Investing | $4.7B | -$60M | -$635M | -$491M | -$512M | |
| Dividends Paid (Ex Special Dividend) | -$53M | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $5B | $4B | $1.5B | $1.8B | $367M | |
| Long-Term Debt Repaid | -$10.3B | -$4.8B | -$2.3B | -$2.3B | -$667M | |
| Repurchase of Common Stock | -- | -$628M | -$669M | -$898M | -$14M | |
| Other Financing Activities | -$69M | -$441M | -$23M | -$56M | -$3M | |
| Cash From Financing | -$5.5B | -$1.8B | -$1.5B | -$1.5B | -$317M | |
| Beginning Cash (CF) | $3.7B | $3B | $2.7B | $1.9B | $1.2B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$687M | -$377M | -$727M | -$617M | $569M | |
| Ending Cash (CF) | $3B | $2.7B | $1.9B | $1.2B | $1.8B | |
| Levered Free Cash Flow | -$391M | $952M | $960M | $954M | $822M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$804M | $539M | -$758M | -$195M | $263M | |
| Depreciation & Amoritzation | $482M | $433M | $382M | $357M | $318M | |
| Stock-Based Compensation | $14M | $24M | $27M | $34M | $20M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$280M | $271M | $415M | $280M | $315M | |
| Capital Expenditures | $91M | $121M | $89M | $86M | $175M | |
| Cash Acquisitions | $199M | $14M | -$199M | -$5M | -- | |
| Cash From Investing | $165M | -$153M | -$336M | -$124M | -$169M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $632M | $228M | $151M | $248M | -- | |
| Long-Term Debt Repaid | -$1.4B | -$219M | -$620M | -$703M | -$56M | |
| Repurchase of Common Stock | -- | -$276M | -$344M | -$143M | -- | |
| Other Financing Activities | -$50M | -$92M | -$2M | -$12M | -$4M | |
| Cash From Financing | -$805M | -$358M | -$814M | -$610M | -$60M | |
| Beginning Cash (CF) | $3.9B | $2.9B | $2.1B | $1.7B | $1.7B | |
| Foreign Exchange Rate Adjustment | $19M | $4M | -$2M | -$13M | -$13M | |
| Additions / Reductions | -$920M | -$240M | -$735M | -$454M | $86M | |
| Ending Cash (CF) | $3B | $2.7B | $1.9B | $1.2B | $1.8B | |
| Levered Free Cash Flow | -$371M | $150M | $326M | $194M | $140M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$146M | $736M | -$566M | $86M | $396M | |
| Depreciation & Amoritzation | $2B | $1.7B | $1.6B | $1.4B | $1.3B | |
| Stock-Based Compensation | $56M | $101M | $108M | $109M | $79M | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $124M | $1.5B | $1.4B | $1.4B | $1.4B | |
| Capital Expenditures | $515M | $549M | $455M | $407M | $576M | |
| Cash Acquisitions | $5.1B | $533M | -$147M | $26M | $26M | |
| Cash From Investing | $4.7B | -$60M | -$635M | -$491M | -$512M | |
| Dividends Paid (Ex Special Dividend) | -$53M | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $5B | $4B | $1.5B | $1.8B | $367M | |
| Long-Term Debt Repaid | -$10.3B | -$4.8B | -$2.3B | -$2.3B | -$667M | |
| Repurchase of Common Stock | -- | -$628M | -$669M | -$898M | -$14M | |
| Other Financing Activities | -$69M | -$441M | -$23M | -$56M | -$3M | |
| Cash From Financing | -$5.5B | -$1.8B | -$1.5B | -$1.5B | -$317M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$687M | -$377M | -$727M | -$617M | $569M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$391M | $952M | $960M | $954M | $822M | |
| Period Ending | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2026-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $736M | -$566M | $86M | $396M | -- | |
| Depreciation & Amoritzation | $1.7B | $1.6B | $1.4B | $1.3B | -- | |
| Stock-Based Compensation | $101M | $108M | $109M | $79M | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $1.5B | $1.4B | $1.4B | $1.4B | -- | |
| Capital Expenditures | $549M | $455M | $407M | $576M | -- | |
| Cash Acquisitions | $533M | -$147M | $26M | $26M | -- | |
| Cash From Investing | -$60M | -$635M | -$491M | -$512M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $4B | $1.5B | $1.8B | $367M | -- | |
| Long-Term Debt Repaid | -$4.8B | -$2.3B | -$2.3B | -$667M | -- | |
| Repurchase of Common Stock | -$628M | -$669M | -$898M | -$14M | -- | |
| Other Financing Activities | -$441M | -$23M | -$56M | -$3M | -- | |
| Cash From Financing | -$1.8B | -$1.5B | -$1.5B | -$317M | -- | |
| Beginning Cash (CF) | $11B | $9.2B | $6.5B | $5.5B | -- | |
| Foreign Exchange Rate Adjustment | $29M | -$97M | -$17M | $3M | -- | |
| Additions / Reductions | -$377M | -$727M | -$617M | $569M | -- | |
| Ending Cash (CF) | $10.8B | $8.4B | $5.9B | $6.1B | -- | |
| Levered Free Cash Flow | $952M | $960M | $954M | $822M | -- | |
Get DXC Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
DXC
Sector
P/E ratio
7.20x
22.66x
PEG ratio
0.02x
0.01x
P/B ratio
0.85x
2.18x
Price / LTM sales
0.22x
1.53x
Growth Metrics
DXC
Sector
Revenue growth
-6.41%
3.98%
Earnings growth
-61.73%
12.51%
Revenue (5-year growth)
-8.05%
6.64%
Earnings forecast
$0.77
$0.11
Profitability
DXC
Sector
Profitability FY 2024
$3.1B
$83M
Return on invested capital
5.63%
0.48%
Return on assets
2.91%
-0.25%
Return on equity
12.05%
0.91%
Earnings Date
Last Earnings Date
May
14
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Aug
13
Balance Sheet
DXC
Sector
Total cash
$1.8B
$53.1M
Short term investments
--
$19.1M
Total assets
$13.2B
$239.8M
Long term debt
$3.6B
$6.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Asana Stock Be in 5 Years?
Asana stock hasn’t given many investors on Wall Street any…
Where Will Dell Stock Be in 5 Years?
So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Sell
31
REGN alert for May 31
Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.
Buy
55
RGC alert for May 31
Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.
Sell
42
AMBA alert for May 31
Ambarella [AMBA] is down 15.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
